Russell Investments Group, Ltd. Inozyme Pharma, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$4.33 - $7.31 $1,874 - $3,165
433 New
433 $1,000
Q4 2021

Jan 21, 2022
SELL
$5.58 - $11.5 $644,579 - $1.33 Million
-115,516 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$11.12 - $19.4 $1.26 Million - $2.19 Million
113,015 Added 4518.79%
115,516 $1.34 Million
Q2 2021

Aug 04, 2021
BUY
$15.19 - $21.2 $37,990 - $53,021
2,501 New
2,501 $42,000

Others Institutions Holding INZY

# of Institutions
91
Shares Held
53.2M
Call Options Held
3.7K
Put Options Held
5.8K
View Full List

About Inozyme Pharma, Inc.

INZY Quotes by TradingView
  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $60.6M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email